STEPHEN D MORRIS, MD
Radiology at Humphreys Blvd, Memphis, TN
License number
Tennessee 30066
Category
Radiology
Type
Diagnostic Radiology
License number
Tennessee 30066
Category
Radiology
Type
Neuroradiology
License number
Tennessee 30066
Category
Radiology
Type
Vascular & Interventional Radiology
Address
Address
6325 Humphreys Blvd, Memphis, TN 38120
Phone
(901) 522-7700
(901) 522-2600 (Fax)
(901) 522-2600 (Fax)
Personal information
See more information about STEPHEN D MORRIS at radaris.comName
Address
Phone
4506 Sanabel Ln, Apison, TN 37302
534 Forrest Hills Dr, Henderson, TN 38340
527 Creek Oak Dr, Murfreesboro, TN 37128
Professional information
Stephen David Morris, Memphis TN
Specialties:
Neuro-Radiologist
Address:
6305 Humphreys Blvd, Memphis, TN 38120
6019 Walnut Grove Rd, Memphis, TN 38120
6325 Humphreys Blvd, Memphis, TN 38120
6019 Walnut Grove Rd, Memphis, TN 38120
6325 Humphreys Blvd, Memphis, TN 38120
Education:
East Tennessee State University, James H. Quillen College of Medicine - Doctor of Medicine
MCG Health Inc - Fellowship - Neuroradiology
MCG Health Inc - Residency - Diagnostic Radiology
Johnson City Medical Center - Internship - Internal Medicine
MCG Health Inc - Fellowship - Neuroradiology
MCG Health Inc - Residency - Diagnostic Radiology
Johnson City Medical Center - Internship - Internal Medicine
Board certifications:
American Board of Radiology Certification in Diagnostic Radiology (Radiology), American Board of Radiology Sub-certificate in Neuroradiology (Radiology)
Dr. Stephen D Morris, Memphis TN - MD (Doctor of Medicine)
Specialties:
Neuroradiology
Address:
Mid-South Imaging & Therapeutics
6305 Humphreys Blvd, Memphis 38120
(901) 747-1000 (Phone)
6305 Humphreys Blvd, Memphis 38120
(901) 747-1000 (Phone)
Certifications:
Diagnostic Radiology, 1996, Neuroradiology, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mid-South Imaging & Therapeutics
6305 Humphreys Blvd, Memphis 38120
Baptist Memorial Hospital
6019 Walnut Grove Rd, Memphis 38120
Baptist Memorial Hospital - Collierville
1500 West Poplar Ave, Collierville 38017
6305 Humphreys Blvd, Memphis 38120
Baptist Memorial Hospital
6019 Walnut Grove Rd, Memphis 38120
Baptist Memorial Hospital - Collierville
1500 West Poplar Ave, Collierville 38017
Education:
Medical School
East Tennessee State University/James H Quillen College Of Medicine
Graduated: 1991
East Tennessee State University
Graduated: 1992
Med College Ga Hospital and Clins
Graduated: 1996
East Tennessee State University/James H Quillen College Of Medicine
Graduated: 1991
East Tennessee State University
Graduated: 1992
Med College Ga Hospital and Clins
Graduated: 1996
Stephen Morris, Memphis TN
Work:
Midsouth Imaging & Therapeutics
6019 Walnut Grove Rd, Memphis, TN 38120 Semmes-Murphey Clinic
6325 Humphreys Blvd, Memphis, TN 38120 Midsouth Imaging & Therapeutics
6225 Humphreys Blvd, Memphis, TN 38120 Midsouth Imaging & Therapeutics
1500 W Poplar Ave, Collierville, TN 38017 Midsouth Imaging & Therapeutics
2100 Exeter Rd, Germantown, TN 38138 Midsouth Imaging & Therapeutics
1995 Highway 51 S, Covington, TN 38019 Midsouth Imaging & Therapeutics
7601 Southcrest Pkwy, Southaven, MS 38671
6019 Walnut Grove Rd, Memphis, TN 38120 Semmes-Murphey Clinic
6325 Humphreys Blvd, Memphis, TN 38120 Midsouth Imaging & Therapeutics
6225 Humphreys Blvd, Memphis, TN 38120 Midsouth Imaging & Therapeutics
1500 W Poplar Ave, Collierville, TN 38017 Midsouth Imaging & Therapeutics
2100 Exeter Rd, Germantown, TN 38138 Midsouth Imaging & Therapeutics
1995 Highway 51 S, Covington, TN 38019 Midsouth Imaging & Therapeutics
7601 Southcrest Pkwy, Southaven, MS 38671
Methods And Compositions For The Diagnosis And Treatment Of Cancer Resistant To Anaplastic Lymphoma Kinase (Alk) Kinase Inhibitors
US Patent:
2013024, Sep 19, 2013
Filed:
Feb 20, 2013
Appl. No.:
13/771948
Inventors:
Stephen W. Morris - Germantown TN, US
Qin Jiang - Memphis TN, US
Xiaoli Cui - Memphis TN, US
Liquan Xue - Cordova TN, US
Qin Jiang - Memphis TN, US
Xiaoli Cui - Memphis TN, US
Liquan Xue - Cordova TN, US
Assignee:
St. Jude Children's Research Hospital - Memphis TN
International Classification:
C12Q 1/68, C12N 9/12
US Classification:
506 9, 536 232, 4353201, 536 2431, 435 611
Abstract:
Compositions and methods for the diagnosis and treatment of a cancer that is resistant to at least one anaplastic lymphoma kinase (ALK) kinase inhibitor are provided herein. The present invention is based on the discovery of mutations within ALK that confer resistance to at least one ALK kinase inhibitor. Polynucleotides and polypeptides having at least one ALK inhibitor resistance mutation are provided and find use in methods and compositions useful in the diagnosis, prognosis, and/or treatment of diseases associated with aberrant ALK activity, more particularly, those that are resistant to at least one ALK kinase inhibitors. Methods and compositions are also provided for the identification of agents that can inhibit the kinase activity and/or reduce the expression level of the ALK resistance mutants.
Fusion Genes Associated With Acute Megakaryoblastoc Leukemias
US Patent:
2004020, Oct 14, 2004
Filed:
Jun 4, 2004
Appl. No.:
10/475917
Inventors:
Stephen Morris - Memphis TN, US
Zhigui Ma - Memphis TN, US
Zhigui Ma - Memphis TN, US
International Classification:
C12Q001/68, G01N033/574, C07H021/04, C07K014/47
US Classification:
435/006000, 435/007230, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500
Abstract:
The invention relates to human nucleotide sequences which occur as a result of the t(1;22)(p13;q13) chromosomal translocation event which is known to occur almost invariable in young children with acute megakaryoblastic leukemia. The translocation results in the formation of fusion genes which encode fusion proteins. The invention provides the nucleotide sequences of transcripts of the fusion genes and the amino acid sequences of the fusion proteins encoded thereby. Also provided are methods for detecting the t(1, 22) translocation, for identifying agents capable of binding to the fusion protein and for identifying agents useful for treating patients with acute megakaryoblastic leukemia.